Inhibitory effect of roxithromycin on biofilm formation of Pseudomonas aeruginosa

Acta Oto-Laryngologica, Supplement

Volumn , Issue 525, 1996, Pages 61-63

  Ozeki, Masashi ^a   Miyamoto, Naoya ^a   Hashiba, Motoyuki ^a   Baba, Shunkichi ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Bacterial biofilm; Erythromycin derivatives; Intractable infection; Living bacteria in the biofilm; Macrolide

Indexed keywords

ROXITHROMYCIN; ANTIINFECTIVE AGENT;

ARTICLE; BIOFILM; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; DRUG EFFECT; HUMAN;

ANTI-BACTERIAL AGENTS; BIOFILMS; HUMANS; PSEUDOMONAS AERUGINOSA; ROXITHROMYCIN;

EID: 0029658769     PISSN: 03655237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Costerton JW, Cheng KJ. The bacterial glycocalyx in nature and disease. Ann Rev Microbiol 1981; 79: 299-324.
2. Costerton JW, Irvin RT. The role of bacterial surface structures in pathogenesis. CRC Crit Rev Microbiol 1981; 35: 303-38.
3. Gristina AG, Costerton J. Bacterial adherence to biomaterals and tissue. J Bone Joint Surg [AM] 1985; 67: 264-73.
4. Brown MRW, Allison DG, Gilbert P. Resistance of bacterial biofilms to antibiotics: a growth-rate related effect? J Antimicrob Chemother 1988; 22: 777-83.
5. Hashiba M, Miyamoto N, Kimura T, Kobayashi T, Baba S. Efficacy of the erythromycin derivative, clarithro-mycin, in the treatment of chronic sinusitis. Am J Rhinol 1994; Suppl 8: 348-9.
6. Peter G, Pulverer G. Pathogenesis and management of Staphylococcus epidermidis "plastic" foreign body infection. J Antimicrob Chemother 1984; 14 (suppl D): 67-71.
7. Chuard C, Lucet JC, Rohner P, et al. Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. J Infect Dis 1991; 163: 1369-73.
8. Fujimaki K, Ikeda Y, Tkahata M, Yasuda T. Characteristics of biofilm formed by Pseudomonas aureginosa in vitro. Chemotherapy 1992; 40: 886-93.